Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Cancers
|
March 6, 2021
CAR-T Therapy, the End of a Chapter or the Beginning of a New One?
Yasser Mostafa Kamel
Cancers
|
February 11, 2023
CAR-T: What Is Next?
Yi-Ju Chen, Bams Abila, Yasser Mostafa Kamel
Cells
|
November 2, 2019
<i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy?
Oliver Britten, Denise Ragusa, Sabrina Tosi, et al.
Future Oncology (London, England)
|
March 13, 2023
Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiology and End Results-Medicare database
Charles Dharmani, Eric Wang, Nora Tu, et al.
Biomarker Research
|
November 26, 2015
Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects
Sabrina Tosi, Yasser Mostafa Kamel, Temitayo Owoka, et al.
Future Oncology (London, England)
|
June 22, 2023
Elderly patients with acute myeloid leukemia who only receive supportive care in the Surveillance, Epidemiology and End Results-Medicare database: demographics, treatment patterns and outcomes
Charles Dharmani, Eric Wang, Nora Tu, et al.
BMC Cancer
|
March 19, 2013
Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
Sant P Chawla, Arthur Staddon, Andrew Hendifar, et al.
International Journal of Hematology
|
September 3, 2017
Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study
Eric S Winer, Howard Safran, Boguslawa Karaszewska, et al.
BMC Cancer
|
September 13, 2012
Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors
Connie L Erickson-Miller, Kodandaram Pillarisetti, Jennifer Kirchner, et al.
Journal of Oncology
|
February 15, 2011
Thrombopoietin receptor levels in tumor cell lines and primary tumors
Connie L Erickson-Miller, Antony Chadderton, Anna Gibbard, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Cancers
|
March 6, 2021
CAR-T Therapy, the End of a Chapter or the Beginning of a New One?
Yasser Mostafa Kamel
Cancers
|
February 11, 2023
CAR-T: What Is Next?
Yi-Ju Chen, Bams Abila, Yasser Mostafa Kamel
Cells
|
November 2, 2019
<i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy?
Oliver Britten, Denise Ragusa, Sabrina Tosi, et al.
Future Oncology (London, England)
|
March 13, 2023
Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiology and End Results-Medicare database
Charles Dharmani, Eric Wang, Nora Tu, et al.
Biomarker Research
|
November 26, 2015
Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects
Sabrina Tosi, Yasser Mostafa Kamel, Temitayo Owoka, et al.
Future Oncology (London, England)
|
June 22, 2023
Elderly patients with acute myeloid leukemia who only receive supportive care in the Surveillance, Epidemiology and End Results-Medicare database: demographics, treatment patterns and outcomes
Charles Dharmani, Eric Wang, Nora Tu, et al.
BMC Cancer
|
March 19, 2013
Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
Sant P Chawla, Arthur Staddon, Andrew Hendifar, et al.
International Journal of Hematology
|
September 3, 2017
Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study
Eric S Winer, Howard Safran, Boguslawa Karaszewska, et al.
BMC Cancer
|
September 13, 2012
Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors
Connie L Erickson-Miller, Kodandaram Pillarisetti, Jennifer Kirchner, et al.
Journal of Oncology
|
February 15, 2011
Thrombopoietin receptor levels in tumor cell lines and primary tumors
Connie L Erickson-Miller, Antony Chadderton, Anna Gibbard, et al.
Page
of 2